Clinical Trial Update: The Everolimus-Transplant Exit Strategy Trial (E-TEST) [Phase 3]

View source ↗

Summary

Phase 3 trial (E-TEST) investigating everolimus in kidney failure; terminated with posted results in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Kidney Failure

Drugs mentioned

• Everolimus (everolimus)

Snippet

Sponsor: Ashtar Chami | Conditions: Kidney Failure, Chronic | Phase 3 | Status: TERMINATED | Results posted: 2015-06-08